Bayesian survival analysis using gamma processes with adaptive time partition

References

• Cox D. Regression models and life-tables. J R Stat Soc Ser B. 1972;34(2):187–220.
   Web of Science ®Google Scholar
• Kalbfleisch J. Non-parametric Bayesian analysis of survival time data. J R Stat Soc Ser B (Methodol). 1978;40(2):214–221.
   Google Scholar
• Hjort NL. Nonparametric Bayes estimators based on beta processes in models for life history data. Ann Stat. 1990;18(3):1259–1294.
   Web of Science ®Google Scholar
• Gelfand AE, Mallick BK. Bayesian analysis of proportional hazards models built from monotone functions. Biometrics. 1995;51(3):843–852.
   PubMed Web of Science ®Google Scholar
• Ibrahim J, Chen M, Sinha D. Bayesian survival analysis. New York (NY): Wiley Online Library; 2005.
   Google Scholar
• Clayton DG. A Monte Carlo method for Bayesian inference in frailty models. Biometrics. 1991;47(2):467–485.
   PubMed Web of Science ®Google Scholar
• Sinha D, Chen MH, Ghosh SK. Bayesian analysis and model selection for interval-censored survival data. Biometrics. 1999;55(2):585–590.
   PubMed Web of Science ®Google Scholar
• Sinha D, Ibrahim JG, Chen MH. A Bayesian justification of Cox's partial likelihood. Biometrika. 2003;90(3):629–641.
   Web of Science ®Google Scholar
• Sinha A, Chi Z, Chen MH. Bayesian inference of hidden gamma wear process model for survival data with ties. Stat Sin. 2015;25(4):1613.
   PubMed Web of Science ®Google Scholar
• Dunson DB, Chen Z. Selecting factors predictive of heterogeneity in multivariate event time data. Biometrics. 2004;60(2):352–358.
   PubMed Web of Science ®Google Scholar
• Sen A, Banerjee M, Li Y, et al. A Bayesian approach to competing risks analysis with masked cause of death. Stat Med. 2010;29(16):1681–1695.
   PubMed Web of Science ®Google Scholar
• Cai B. Bayesian semiparametric frailty selection in multivariate event time data. Biom J Math Methods Biosci. 2010;52(2):171–185.
   Google Scholar
• Sreedevi E, Sankaran P. A semiparametric Bayesian approach for the analysis of competing risks data. Commun Stat-Theory Methods. 2012;41(15):2803–2818.
   Web of Science ®Google Scholar
• Ouyang B, Sinha D, Slate EH, et al. Bayesian analysis of recurrent event with dependent termination: an application to a heart transplant study. Stat Med. 2013;32(15):2629–2642.
   PubMed Web of Science ®Google Scholar
• Lee KH, Chakraborty S, Sun J. Bayesian variable selection in semiparametric proportional hazards model for high dimensional survival data. Int J Biostat. 2011;7(1):21.
   Google Scholar
• Savitsky T, Vannucci M, Sha N. Variable selection for nonparametric Gaussian process priors: models and computational strategies. Stat Sci Rev J Inst Math Stat. 2011;26(1):130.
   PubMed Web of Science ®Google Scholar
• Gu X, Yin G, Lee JJ. Bayesian two-step lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. Contemp Clin Trials. 2013;36(2):642–650.
   PubMed Web of Science ®Google Scholar
• Zhao L, Feng D, Bellile EL, et al. Bayesian random threshold estimation in a Cox proportional hazards cure model. Stat Med. 2014;33(4):650–661.
   PubMed Web of Science ®Google Scholar
• Lee KH, Chakraborty S, Sun J. Survival prediction and variable selection with simultaneous shrinkage and grouping priors. Stat Anal Data Min. 2015;8(2):114–127.
   Web of Science ®Google Scholar
• Gelfand AE, Kottas A. Bayesian semiparametric regression for median residual life. Scandinavian J Stat. 2003;30(4):651–665.
   Web of Science ®Google Scholar
• Cho H, Ibrahim JG, Sinha D, et al. Bayesian case influence diagnostics for survival models. Biometrics. 2009;65(1):116–124.
   PubMed Web of Science ®Google Scholar
• Zhao L, Shi J, Shearon TH, et al. A Dirichlet process mixture model for survival outcome data: assessing nationwide kidney transplant centers. Stat Med. 2015;34(8):1404–1416.
   PubMed Web of Science ®Google Scholar
• Burridge J. Empirical Bayes analysis of survival time data. J R Stat Soc Ser B. 1981;43(1):65–75.
   Google Scholar
• Haneuse S, Rudser KD, Gillen DL. The separation of timescales in Bayesian survival modeling of the time-varying effect of a time-dependent exposure. Biostatistics. 2008;9(3):400–410.
   PubMed Web of Science ®Google Scholar
• Arjas E, Gasbarra D. Nonparametric Bayesian inference from right censored survival data, using the Gibbs sampler. Stat Sin. 1994;4(2):505–524.
   Web of Science ®Google Scholar
• Lee KH, Haneuse S, Schrag D, et al. Bayesian semiparametric analysis of semicompeting risks data: investigating hospital readmission after a pancreatic cancer diagnosis. J R Stat Soc Ser C. 2015;64(2):253–273.
   PubMed Web of Science ®Google Scholar
• Green PJ. Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika. 1995;82:711–732.
   Web of Science ®Google Scholar
• McKeague IW, Tighiouart M. Bayesian estimators for conditional hazard functions. Biometrics. 2000;56(4):1007–1015.
   PubMed Web of Science ®Google Scholar
• Spiegelhalter DJ, Best NG, Carlin BP, et al. Bayesian measures of model complexity and fit. J R Stat Soc Ser B. 2002;64(4):583–639.
   Google Scholar
• Geisser S, Eddy WF. A predictive approach to model selection. J Am Stat Assoc. 1979;74(365):153–160.
   Web of Science ®Google Scholar
• Celeux G, Forbes F, Robert CP, et al. Deviance information criteria for missing data models. Bayesian Anal. 2006;1(4):651–673.
   Web of Science ®Google Scholar
• Chen MH, Shao QM, Ibrahim JG. Monte carlo methods in Bayesian computation. New York (NY): Springer; 2012.
   Google Scholar
• Hanson TE. Inference for mixtures of finite polya tree models. J Am Stat Assoc. 2006;101(476):1548–1565.
   Web of Science ®Google Scholar
• Lee KH, Dominici F, Schrag D, et al. Hierarchical models for semicompeting risks data with application to quality of end-of-life care for pancreatic cancer. J Am Stat Assoc. 2016;111(515):1075–1095.
   PubMed Web of Science ®Google Scholar
• Alvares D, Haneuse S, Lee C, et al. SemiCompRisks: an R package for the analysis of independent and cluster-correlated semi-competing risks data. R J. 2019;11(1):376.
   PubMedGoogle Scholar
• Gelman A, Carlin JB, Stern HS, et al. Bayesian data analysis. Boca Raton (FL): CRC Press; 2013.
   Google Scholar
• Kardaun O. Statistical survival analysis of male larynx-cancer patients – a case study. Stat Neerl. 1983;37(3):103–125.
   Google Scholar
• Schumacher M, Bastert G, Bojar H, et al. Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. german breast cancer study group. J Clinical Oncol. 1994;12(10):2086–2093.
   PubMed Web of Science ®Google Scholar
• Van De Vijver MJ, He YD, Van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. New England J Med. 2002;347(25):1999–2009.
   PubMed Web of Science ®Google Scholar
• Shapiro CL, Gelman RS, Hayes DF, et al. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. JNCI: J Nat Cancer Inst. 1993;85(10):812–817.
   PubMedGoogle Scholar
• Rosen O, Wood S, Stoffer DS. Adaptspec: adaptive spectral estimation for nonstationary time series. J Am Stat Assoc. 2012;107(500):1575–1589.
   Web of Science ®Google Scholar